sorafenib has been researched along with Cancer of the Urinary Tract in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, K; Han, HJ; Jung, H; Kim, JH; Lee, JY; Yoon, HY; Yoon, KA | 1 |
| Deshpande, H; Donadio, A; Hurwitz, ME; Kelly, WK; Markowski, P; Mehnert, JM; Mortazavi, A; Patel, J; Petrylak, DP; Stein, MN; Yao, X | 1 |
| Albers, P; de Geeter, P; Fenner, M; Feyerabend, S; Hakenberg, O; Heidenreich, A; Heinzer, H; Kamradt, J; Klotz, T; Krege, S; Kühn, M; Retz, M; Rexer, H; Roigas, J; Schrader, M; vom Dorp, F; Wülfing, C; Zastrow, S | 1 |
| Blattler, C; Eisen, A; Hotte, SJ; McWhirter, E; Moore, MJ; Mukherjee, SD; Sridhar, SS; Tannock, IF; Wang, L; Winquist, E; Wright, JJ | 1 |
| Fujisawa, M; Miyake, H | 1 |
1 review(s) available for sorafenib and Cancer of the Urinary Tract
| Article | Year |
|---|---|
[Molecular targeted therapy for renal cell carcinoma and other urological cancers].
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Quality of Life; Sorafenib; Sunitinib; Urologic Neoplasms | 2010 |
3 trial(s) available for sorafenib and Cancer of the Urinary Tract
| Article | Year |
|---|---|
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Progression-Free Survival; Sorafenib; Survival Analysis; Urologic Neoplasms | 2018 |
Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Humans; Male; Niacinamide; Phenylurea Compounds; Prospective Studies; Sorafenib; Treatment Outcome; Urologic Neoplasms | 2014 |
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Treatment Outcome; Urologic Neoplasms; Urothelium | 2011 |
1 other study(ies) available for sorafenib and Cancer of the Urinary Tract
| Article | Year |
|---|---|
Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target.
Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Culture Techniques; Cells, Cultured; Dogs; Female; Mice; Mutation; Proto-Oncogene Proteins B-raf; Sorafenib; Urologic Neoplasms; Xenograft Model Antitumor Assays | 2021 |